IMMX Stock Drops Significantly on Chief Medical Officer News-Immix Biopharma Investors Encouraged to Contact Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of Immix Biopharma investors following reports regarding a company executive. STAT News reported that Ronald Fischer, identified as an executive at Immix, was arrested after being a fugitive since 2005, which coincided with a 13% intraday drop in the stock.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.